Biomolecules and Biomedicine

Home
Bosnia And Herzegovina
Sarajevo
Biomolecules and Biomedicine

The Biomolecules and Biomedicine is an international, peer-reviewed journal. Journal IF 2023: 3.1 Broad readership and scope. Open Access. Editorial Board.
(3)

The Biomolecules and Biomedicine (formerly, the Bosnian Journal of Basic Medical Sciences, BJBMS) is а premier venue for preclinical and clinical biomedical science discoveries. The journal was founded in 1998 and is published by the Association of Basic Medical Sciences, a nonprofit honor organization of physician-scientists. The Biomolecules and Biomedicine reaches readers across a wide range of

medical disciplines and sectors. The Journal publishes basic and translational/clinical research submissions and reviews in all biomedical specialties, including Genetics and Molecular biology, Immunology, Microbiology, Pathology, Biochemistry, Pharmacology, Anatomy, Biomaterials, New and Emerging Research and Diagnostic Methods, New and Emerging Medical Entities, and others. All research is available to the public for free. The Biomolecules and Biomedicine deposits published articles in PubMed Central, satisfying the NIH Public Access Policy and other similar funding agency requirements. Renowned international experts in the Journal's Editorial Board, together with external peer-reviewers, select the best submissions for publication. High visibility
Open Access: articles are freely available to readers immediately after publication. Highly accessed online content: more than 350,000 readers/month (100,000 at PubMed Central (April 2024); 120,000 at Journal's website (April 2024); more than 130,000 at Web of Science, Scopus, Google Scholar, and others). Newsletters: more than 20,000 registered users receive a newsletter tailored to their field of interest. Social media: articles are promoted through various social media channels (Twitter, LinkedIn, Facebook)
Advance online: all accepted articles are published Advance online and Ahead of print on PubMed within 3 days of acceptance, with citable DOIs, to make the article accessible as fast as possible. Print circulation: 200 copies of print issues are sent to major libraries, institutes, universities, conferences, and subscribers worldwide. BiomolBiomed Viewpoints: Journal's blog promotes authors and their research by publishing plain language summaries for a broad audience and media, as well as commentaries, interviews, news, and stories related to science and research. Indexing and abstracting
SCIE (Science Citation Index Expanded), Web of Science, Clarivate Analytics
JCR (Journal Citation Reports®), Clarivate Analytics
PubMed/MEDLINE (Biomol Biomed)
PubMed/MEDLINE (BJBMS)
PubMed Central (PMC)
SCOPUS
SJR (Scimago Journal and Country Rank) (BiomolBiomed)
SJR (Scimago Journal and Country Rank) (BJBMS)
DOAJ
SCILIT (BiomolBiomed)
SCILIT (BJBMS)
EBSCO
PROQUEST
Dimensions
Semantic Scholar
Google Scholar
EMBASE/Excerpta Medica
Europe PubMed Central
Medscape
ISSN Portal
ROAD
HINARI
CAS
X-MOL
CNKI
many libraries

Timely publication
The 2023 peer review performance metrics:

Number of submissions (2023): 1288
Average time from submission to initial decision (reject or peer review): 2 days
Average peer-review time and decision: 22 days
Average time from acceptance to advance online publication: 2 days
Average number of reviews received per manuscript: 4
Acceptance Rate: 15%
Meaningful metrics
The success of the articles published in BiomolBiomed is tracked in real-time by individualized Article-Level Metrics (Dimensions and PlumX). These reflect the viewership, download rates, social sharing, citations, field citation ratio, and relative citation ratio for each published article in real-time, and help you illustrate the impact of your research

Journal Impact Factor® (JCR/Clarivate Analytics):
2023 = 3.1 (Q2)
2022 = 3.4
2021 = 3.759
2020 = 3.363
2019 = 2.050
2018 = 1.458
2017 = 1.432
2016 = 0.906
2015 = 0.652
2014 = 0.443
CiteScore® (SCOPUS/Elsevier)
2023 = 7.4 ( #54/636 91st percentile)
2022 = 5.3
2021 = 5.20
2020 = 4.00
2019 = 3.20
2018 = 1.43
2017 = 1.31
2016 = 0.94
2015 = 0.78
2014 = 0.59

Address

Sarajevo
71000

Website

https://www.biomolbiomed.com/

Alerts

Be the first to know and let us send you an email when Biomolecules and Biomedicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Biomolecules and Biomedicine:

Shortcuts

Our Story

The BJBMS (Bosnian Journal of Basic Medical Sciences) is а premier venue for discoveries in basic and clinical biomedical science. The BJBMS was founded in 1998 and is published by the Association of Basic Medical Sciences, a nonprofit honor organization of physician-scientists.

Broad readership and scope. The BJBMS reaches readers across a wide range of medical disciplines and sectors. The journal publishes basic and translational/clinical research submissions and reviews in all biomedical specialties, including Genetics and Molecular biology, Immunology, Microbiology, Pathology, Biochemistry, Pharmacology, Anatomy, Biomaterials, new and emerging research and diagnostic methods, new and emerging medical entities, and others.

Open access. All research is available to the public for free. The BJBMS deposits published articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.

Editorial Board. Renowned international experts in the journal's Editorial Board, together with external peer-reviewers select the best of the submissions for publication.